Skip to content

Search

Search managers or tickers

Baupost Group

Q3 2016 13F · by Seth Klarman, portfolio manager

As of
Sep 30, 2016
Filed
Nov 14, 2016
US stock
$7.0B · prev $7.3B
Positions
43 · prev 38
Options notional
$0
Documents
1· no amendments

Picture99.4% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 99.4%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.6%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves29 since the prior filing

The book

Concentrated · behaves like 14 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

High turnover · 83% a year, about 1.2 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions49% of US stock

  1. LNG Cheniere Energy Inc trimmed+2.06 pp trimmed+2.0617.4%
  2. VSAT Viasat Inc held held12.3%
  3. SYF Synchrony Financial new+7.03 pp new+7.037.0%
  4. ACT Allergan PLC held held6.6%
  5. AR Antero Resources Corporation held held5.6%

Positions43 in this filing · 7 exited

LNGCheniere Energy Inc17.35%27,842,957$1.2Btrimmed−7%+2.06 pp11 q
VSATViasat Inc12.31%11,533,137$861Mheld—14 q
SYFSynchrony Financial7.03%17,565,000$492Mnew+7.03 ppnew
ACTAllergan PLC6.59%2,001,978$461Mheld—3 q
ARAntero Resources Corporation5.59%14,505,881$391Mheld—9 q
PBFPbf Energy Inc.5.09%15,724,175$356Madded+48%+1.64 pp13 q
unresolvedDell Technologies Inc4.55%6,652,459$318Mnew+4.55 ppnew
unresolvedTwenty First Centy Fox Inc4.41%12,746,469$309Madded+66%+1.57 pp5 q
TBPHTheravance Biopharma, Inc.3.81%7,350,991$266Mheld—10 q
PYPLPayPal Holdings, Inc.2.93%5,000,000$205Mtrimmed−12%+0.11 pp5 q
unresolvedTwenty First Centy Fox Inc2.57%7,278,100$180Mheld—5 q
INVAInnoviva, Inc.2.35%14,931,483$164Mtrimmed−15%−0.18 pp3 q
VRTVVeritiv Corporation2.18%3,044,385$153Mheld—9 q
unresolvedKeryx Biopharmaceuticals Inc1.96%25,791,678$137Mheld—11 q
unresolvedNorthstar Asset Mgmt Group I1.83%9,913,654$128Mnew+1.83 ppnew
OLNOlin Corp.1.81%6,181,302$127Mtrimmed−42%−1.83 pp5 q
VMWVMware, Inc1.68%1,603,889$118Mtrimmed−29%−0.08 pp3 q
ATRAGBXAtara Biotherapeutics Inc1.64%5,359,632$115Mheld—8 q
unresolvedForward Pharma A/S1.61%5,367,300$113Mheld—8 q
unresolvedLiberty Interactive Corp1.41%2,469,533$98Mheld—2 q
unresolvedColony Finl Inc1.16%4,445,936$81Mnew+1.16 ppnew
unresolvedChipmos Tech Bermuda Ltd1.06%3,751,853$74Mheld—14 q
unresolvedNorthstar Rlty Fin Corp1.04%5,498,261$72Mnew+1.04 ppnew
unresolvedKlx Inc1.01%2,000,000$70Mheld—7 q
unresolvedSilver Run Acquisition Corp0.84%3,750,000$59Mheld—2 q
unresolvedAmerican Intl Group Inc0.79%2,594,317$55Madded+2%+0.14 pp14 q
NGNovaGold Resources Inc.0.76%9,500,000$53Mheld—14 q
BATRKAtlanta Braves Holdings, Inc. Series C0.74%2,994,010$52Mheld—2 q
ODPOffice Depot Inc0.66%13,000,000$46Mnew+0.66 ppnew
unresolvedCascadian Therapeutics Inc0.59%25,000,000$41Mheld—2 q
unresolvedConyers Pk Acquisition0.53%3,712,500$37Mnew+0.53 ppnew
PRTKParatek Pharmaceuticals, Inc.0.38%2,044,498$27Mheld—8 q
unresolvedSaban Cap Acquisition Corp0.34%2,326,500$23Mnew+0.34 ppnew
CACCCredit Acceptance Corp0.29%100,000$20Mheld—2 q
RUNSunrun Inc0.26%2,848,082$18Mheld—5 q
KINKindred Biosciences, Inc.0.21%3,011,584$15Mtrimmed−0%+0.06 pp12 q
BATRAAtlanta Braves Holdings, Inc. Series A0.20%800,000$14Mheld—2 q
unresolvedOrexigen Therapeutics Inc0.11%2,226,839$7Mnew+0.11 ppnew
unresolvedTobira Therapeutics Inc0.09%160,829$6Mnew+0.09 ppnew
unresolvedCitigroup Inc0.08%102,553,207$5Mheld—14 q
unresolvedSilver Run Acquisition Corp0.08%950,000$5Mtrimmed−24%+0.06 pp2 q
TMQTrilogy Metals Inc0.08%10,600,758$6Mnew+0.08 ppnew
unresolvedConyers Pk Acquisition0.02%1,237,500$1Mnew+0.02 ppnew
unresolvedE M C Corp Mass—−56,961,725—exited−21.12 pp—
CCitigroup Inc.—−5,167,000—exited−2.99 pp—
CARAvis Budget Group, Inc.—−1,787,227—exited−0.79 pp—
unresolvedSunedison Semiconductor Ltd—−8,372,979—exited−0.68 pp—
unresolvedOch Ziff Cap Mgmt Group—−3,373,891—exited−0.17 pp—
unresolvedOrexigen Therapeutics Inc—−22,268,399—exited−0.13 pp—
unresolvedNovacopper Inc—−10,600,758—exited−0.07 pp—

Other 13(f) securities

Options 0

None in this filing

Notes 1

Issue% of notesPrincipalValue
Innoviva Inc100.00%48,230,000$41M

Source

Form
13F-HR
Reading
0 defects · 21 unresolved
Options
none in this filing
SEC cross-check
SEC data set not published yet